Related Experiment Video
Updated: Jul 13, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Clinical trials finance and operations.
1KarenZupko & Associates, 625 N. Michigan Avenue, #702, Chicago, IL 60611, USA. jobrien@karenzupko.com
The Journal of Medical Practice Management : MPM
|July 7, 2007
Summary
The 2000 National Coverage Decision expanded clinical trial participation by covering routine services. Proper financial analysis and negotiation are crucial for practices to benefit from clinical trial involvement.
Area of Science:
- Health Services Research
- Clinical Trial Management
- Healthcare Policy
Background:
- The 2000 National Coverage Decision aimed to increase patient and physician involvement in clinical trials.
- It mandated governmental coverage for routine clinical trial services.
- Clinical trial participation offers practice growth and advances medical science.
Purpose of the Study:
- To analyze the impact of the National Coverage Decision on clinical trial participation.
- To highlight the financial considerations for healthcare practices engaging in clinical trials.
Main Methods:
- Policy analysis of the National Coverage Decision (2000).
- Review of financial implications for clinical trial participation.
- Assessment of practice management strategies for clinical trials.
Main Results:
- The decision facilitated broader access to clinical trials by covering routine care.
- Effective participation requires meticulous coverage analysis, budgeting, and negotiation.
- Without these, clinical trials can pose a financial burden rather than a benefit.
Conclusions:
- The National Coverage Decision has the potential to boost clinical trial engagement.
- Strategic financial planning and contract negotiation are essential for practices to realize benefits.
- Ensuring proper financial groundwork is key to successful clinical trial participation.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...